EPIGENESIS
DEAD

Serial Number

78790746

Owner

Epigenesis Pharmaceuticals, LLC

Attorney

ALBERT P. HALLUIN

Filing Date

Jan 12, 2006

Add to watchlist:

No watchlists yet
View on USPTO

EPIGENESIS Trademark

Serial Number: 78790746

EPIGENESIS is a trademark filed by Epigenesis Pharmaceuticals, LLC on January 12, 2006. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Epigenesis Pharmaceuticals, LLC (13 trademarks)

2009 Eastpark Boulevard
Cranbury, NJ 08512

Entity Type: 16

Trademark Details

Filing Date

January 12, 2006

Registration Date

Not Registered

Published for Opposition

September 19, 2006

Goods & Services

medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 11, 2010 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 11, 2010 ABN6
SOU EXTENSION 5 GRANTED
Jun 30, 2009 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 30, 2009 AITU
SOU EXTENSION 5 FILED
Jun 8, 2009 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 8, 2009 EEXT
SOU EXTENSION 4 GRANTED
Dec 1, 2008 EX4G
SOU EXTENSION 4 FILED
Dec 1, 2008 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 1, 2008 EEXT
SOU EXTENSION 3 GRANTED
Jun 4, 2008 EX3G
SOU EXTENSION 3 FILED
Jun 4, 2008 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 4, 2008 EEXT
SOU EXTENSION 2 GRANTED
Dec 3, 2007 EX2G
SOU EXTENSION 2 FILED
Dec 3, 2007 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 3, 2007 EEXT
SOU EXTENSION 1 GRANTED
Jun 5, 2007 EX1G
SOU EXTENSION 1 FILED
Jun 5, 2007 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 5, 2007 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 12, 2006 NOAM
PUBLISHED FOR OPPOSITION
Sep 19, 2006 PUBO
NOTICE OF PUBLICATION
Aug 30, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 27, 2006 PREV
ASSIGNED TO LIE
Jul 21, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 17, 2006 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 13, 2006 XAEC
EXAMINERS AMENDMENT E-MAILED
Jul 13, 2006 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 13, 2006 CNEA
ASSIGNED TO EXAMINER
Jun 29, 2006 DOCK
NEW APPLICATION ENTERED
Jan 18, 2006 NWAP